| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/24/2005 | US20050261187 Methods and compositions relating to MEK5 and cardiac hypertrophy and dilated cardiomyopathy |
| 11/24/2005 | US20050261182 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin |
| 11/24/2005 | US20050261179 Vasoregulating compounds and methods of their use |
| 11/24/2005 | US20050261176 Compositions and methods relating to novel compounds and targets thereof |
| 11/24/2005 | US20050261171 Combination cancer therapy |
| 11/24/2005 | US20050261167 Compositions for sleeping disorders |
| 11/24/2005 | US20050261165 compounds that inhibit activity of the AcrAB or AcrAB-like efflux pump are identified as compounds which reduce antibiotic resistance in a microbe that has 2 chromosomal mutations in a gene encoding an antibiotic target that renders it resistant and increased expression of at least one efflux pump |
| 11/24/2005 | US20050261164 Remedy for urinary frequency and urinary incontinence |
| 11/24/2005 | US20050261163 Pharmaceutical products, preparation and uses thereof |
| 11/24/2005 | US20050261162 Pharmaceutical composition for preventing and treating cancer and treating an inflammation |
| 11/24/2005 | US20050261148 Enhanced disinfecting compositions for medical device treatments |
| 11/24/2005 | US20050260731 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 11/24/2005 | US20050260651 Enhanced biologically active conjugates |
| 11/24/2005 | US20050260616 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 11/24/2005 | US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof |
| 11/24/2005 | US20050260597 Transfection reagents |
| 11/24/2005 | US20050260581 Gonococcal proteins and nucleic acids |
| 11/24/2005 | US20050260577 Detection of neurodegenerative disorders |
| 11/24/2005 | US20050260290 Botanical anti-inflammatory compositions and methods |
| 11/24/2005 | US20050260289 extracts from Lightyellow Sophora Root, Turmeric, Magnolia Bark, Moutan Bark extract, Isatis Leaf, Borneo Camphor Tree, Amur Cork Tree, Angelicae Dahuricae Root, Lemon, Smartweed extract, Licorice, Cnidii Rhizoma, Japanese Angelica Root extract, salicylic acid, resorcinol, alcohol, and water; eczema |
| 11/24/2005 | US20050260285 Healthy prostate formula |
| 11/24/2005 | US20050260283 Composition for prevention and treatment of colon adenomas |
| 11/24/2005 | US20050260280 Contact lens and eye drop rewetter compositions and methods |
| 11/24/2005 | US20050260277 Method and formula for anti-tumor and anti-matastatic effect |
| 11/24/2005 | US20050260272 Method of forming microparticles that include a bisphosphonate and a polymer |
| 11/24/2005 | US20050260268 Methods and dosage forms for controlled delivery of alprazolam |
| 11/24/2005 | US20050260263 Sustained release formulation for sparingly soluble main drugs |
| 11/24/2005 | US20050260262 Comprising risedronate, a chelating agent, and, means for effecting delayed release of the risedronate and the chelating agent in the small intestine; enteric coating |
| 11/24/2005 | US20050260261 Neutral-cationic lipid for nucleic acid and drug delivery |
| 11/24/2005 | US20050260255 Adhesive patch |
| 11/24/2005 | US20050260254 Hot melt tts for administering rotigotine |
| 11/24/2005 | US20050260253 Transmucosal gel formulations |
| 11/24/2005 | US20050260240 Rain-fast bioactive compositions |
| 11/24/2005 | US20050260238 Cosmetic compositions comprising wholly hydrophilic block copolymers and particular anti-fungal agents |
| 11/24/2005 | US20050260236 Direct compression polymer tablet core |
| 11/24/2005 | US20050260217 Co-encapsulated WT1 polypeptide and immunostimulant microsphere formulations and methods thereof |
| 11/24/2005 | US20050260193 Steroid sparing agents and methods of using same |
| 11/24/2005 | US20050260188 Cross-linked gels of chemically activated carboxypolysaccharides and polyalkylene oxides |
| 11/24/2005 | US20050260187 Therapeutic and cosmetic uses of heparanases |
| 11/24/2005 | US20050260181 Compositions and methods for tissue repair |
| 11/24/2005 | US20050260177 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 11/24/2005 | US20050260174 Systems and methods for treating patients with processed lipoaspirate cells |
| 11/24/2005 | US20050260171 Compositions containing bacteriophages and method of using bacteriophages to treat infections |
| 11/24/2005 | US20050260153 Facilitation of iontophoresis using charged moieties |
| 11/24/2005 | US20050260145 Oil soluble compositions |
| 11/24/2005 | US20050260140 Mucolytic and anti-elastase compounds and methods of use thereof |
| 11/24/2005 | US20050260139 Pharmaceutical compositions based on anticholinergics and CCR2 receptor antagonists |
| 11/24/2005 | US20050260138 Producton and use of a gaseous vapor disinfectant |
| 11/24/2005 | US20050260128 Low toxicity carborane-containing 5, 10, 15, 20-tetraphenylporphyrin compounds; use in the treatment, visualization, and diagnosis of tumors such as in boron neutron capture therapy (BNCT) and photodynamic therapy (PDT) |
| 11/24/2005 | US20050260126 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 11/24/2005 | US20050260098 Oligosaccharide-containing compositions and uses thereof |
| 11/24/2005 | US20050259281 Method, apparatus and computer program for transforming digital colour images |
| 11/24/2005 | DE202005014019U1 Composition for use as a saliva substitute and for treating dryness of the mouth and throat comprises carrageenan or alginate |
| 11/24/2005 | DE202005012984U1 Oral combination, useful in the treatment and/or prophylaxis of eye diseases e.g. glaucoma, comprises one or more dosage units comprising e.g. zinc oxide; highly purified fish oil; ascorbic acid and optionally carotenoid, cinnamon |
| 11/24/2005 | DE202004016646U1 Lozenge used for topical treatment of inflammatory disorders of mouth and throat comprise octenidine dichloride |
| 11/24/2005 | DE10301105B4 Verwendung von 2-Amino-2H-chinazolin-Derivaten zur Behandlung von myeloproliferativen Erkrankungen, Bluthochdruck und Bronchodilation Use of 2-amino-2H-quinazoline derivatives for the treatment of myeloproliferative diseases, high blood pressure and bronchodilation |
| 11/24/2005 | DE102004028302B4 Stimulierung der Synthese und der Aktivität einer Isoform der Lysyloxidase-ähnlichen LOXL zum Stimulieren der Bildung von elastischen Fasern Stimulation of the synthesis and the activity of one isoform of the lysyl oxidase-like LOXL for stimulating the formation of elastic fibers |
| 11/24/2005 | DE102004021992A1 Topische Zubereitung enthaltend Ambroxol The topical preparation containing ambroxol |
| 11/24/2005 | DE102004021281A1 Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin Use of meloxicam formulations in veterinary medicine |
| 11/24/2005 | DE102004019753A1 Antiinflammatory finishing of hygiene articles, e.g. diapers or tampons, to prevent inflammation on contact with skin, using phytosterols, especially from avocado oil non-saponifiable components |
| 11/24/2005 | DE102004019743A1 Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens Multiphase product for contraception based on a natural estrogen |
| 11/24/2005 | DE102004019413A1 Use of substances (e.g. nucleic acids, proteins and peptides), which restrain/reduce the expression and/or activity of protein kinase C-epsilon for the treatment/prevention of e.g. circulatory and vascular diseases |
| 11/24/2005 | CA2821239A1 Phycotoxins and uses thereof |
| 11/24/2005 | CA2820168A1 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | CA2816163A1 Methods and kits to detect hereditary angioedema type iii |
| 11/24/2005 | CA2607589A1 Methods of treating wounds with gonyautoxins |
| 11/24/2005 | CA2607206A1 Transdermal administration of phycotoxins |
| 11/24/2005 | CA2606530A1 Phycotoxins and uses thereof |
| 11/24/2005 | CA2606472A1 The use of kauranes compounds in the manufacture of medicament |
| 11/24/2005 | CA2567223A1 Treatment of diseases associated with altered level of amyloid beta peptides |
| 11/24/2005 | CA2567166A1 Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions |
| 11/24/2005 | CA2567154A1 Novel pyridazinone derivatives as inhibitors of cdk2 |
| 11/24/2005 | CA2566917A1 Compounds containing a n-heteroaryl moiety linked to fused ring moieties for the inhibition of nad(p)h oxidases and platelet activation |
| 11/24/2005 | CA2566837A1 Anti acne skincare composition and skincare article |
| 11/24/2005 | CA2566821A1 7-substituted benzimidazoles and their use as inhibitors of gastric acid secretion |
| 11/24/2005 | CA2566721A1 Phospholipase c gamma modulation and uses thereof for management of pain and nociception |
| 11/24/2005 | CA2566707A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 11/24/2005 | CA2566677A1 Combination therapy for treating hepatitis virus infection |
| 11/24/2005 | CA2566625A1 Thiazole compound and use thereof |
| 11/24/2005 | CA2566517A1 Improved konjac glucomannan cellulase hydrolysate prebiotics |
| 11/24/2005 | CA2566477A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 11/24/2005 | CA2566421A1 Thienopyridine derivatives, production method and use thereof |
| 11/24/2005 | CA2566346A1 Prevention of arterial restenosis with active vitamin d compounds |
| 11/24/2005 | CA2566340A1 Resistance-repellent retroviral protease inhibitors |
| 11/24/2005 | CA2566332A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 11/24/2005 | CA2566326A1 Peritoneal dialysis solution |
| 11/24/2005 | CA2566325A1 Film-shaped estriol-containing medicament for oral administration |
| 11/24/2005 | CA2566212A1 Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives |
| 11/24/2005 | CA2566210A1 Oxo-substituted cyclohexyl-1,4-diamine derivatives |
| 11/24/2005 | CA2566190A1 Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration |
| 11/24/2005 | CA2566188A1 Use of targeted oxidative therapeutic formulation in bone regeneration |
| 11/24/2005 | CA2566185A1 Formulations with controlled release of active ingredient |
| 11/24/2005 | CA2566180A1 Use of targeted oxidative therapeutic formulation in treatment of cancer |
| 11/24/2005 | CA2566158A1 Kinase inhibitors as therapeutic agents |
| 11/24/2005 | CA2565984A1 1h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
| 11/24/2005 | CA2565953A1 Piperidine derivatives as nk1 and nk3 antagonists |
| 11/24/2005 | CA2565915A1 Inhalation powder formulations containing enantiomerically pure beta-agonists |
| 11/24/2005 | CA2565583A1 Pharmaceutical solution formulations containing 17-aag |
| 11/24/2005 | CA2565551A1 Cellulose and acrylic based polymers and the use thereof for the treatment of infectious diseases |
| 11/24/2005 | CA2565548A1 Substituted cycloalkyl derivatives for use in the treatment of respiratory diseases |